Activin A Receptor Type IB Antibody (YA1989)(PBS only)

Art. -Nr.: HY-P82244A: Data Sheet COA
SDS
User Guide for Antibodies
FAQs
Technical Support

Activin A Receptor Type IB Antibody (YA1989) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Activin A Receptor Type IB.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Größe	Verfügbarkeit	Menge
20 μL	Auf Lager	Estimated Time of Arrival: December 31
50 μL	Auf Lager	Estimated Time of Arrival: December 31
100 μL	Auf Lager	Estimated Time of Arrival: December 31
250 μL	Angebot einholen

or Massenanfrage

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

WB: Western Blot;
IHC-P: Immunohistochemistry-Paraffin;
IHC-F: Immunohistochemistry-Frozen;
ICC/IF: Immunocytochemistry/Immunofluorescence;
IF-Tissue: Immunofluorescence-Tissue;
mIHC: Multiplex Immunohistochemical;
IP: Immunoprecipitation;
ChIP: Chromatin Immunoprecipitation;
FC: Flow Cytometry;
ELISA: Enzyme Linked Immunosorbent Assay

Product Detail
Background
Beschreibung

Beschreibung

Activin A Receptor Type IB Antibody (YA1989) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Activin A Receptor Type IB.

Host

Rabbit

Molekulargewicht

Predicted band size: 57 kDa;

Observed band size: 57 kDa

Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.

Species Reactivity

Human, Mouse, Rat

SwissProt ID

P36896

Gene ID

91 [NCBI]

Immunogen

A synthetic peptide of human Activin A Receptor Type IB

Application &
Dilution Ratio

Application	Dilution Ratio
WB WB: Western Blot	1:1000-1:5000
FC FC: Flow Cytometry	1:20-1:100

Reinheit	Affinity Purified	Conjugation	Non-conjugated
Isotype	IgG

Appearance

Liquid

Formulation

Supplied in 0.01M PBS, pH 7.4.

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Versand

Shipping with blue ice.

Background

Function：Transmembrane serine/threonine kinase activin type-1 receptor forming an activin receptor complex with activin receptor type-2 (ACVR2A or ACVR2B). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating a many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in follicular development in the ovary. Within the receptor complex, type-2 receptors (ACVR2A and/or ACVR2B) act as a primary activin receptors whereas the type-1 receptors like ACVR1B act as downstream transducers of activin signals. Activin binds to type-2 receptor at the plasma membrane and activates its serine-threonine kinase. The activated receptor type-2 then phosphorylates and activates the type-1 receptor such as ACVR1B. Once activated, the type-1 receptor binds and phosphorylates the SMAD proteins SMAD2 and SMAD3, on serine residues of the C-terminal tail. Soon after their association with the activin receptor and subsequent phosphorylation, SMAD2 and SMAD3 are released into the cytoplasm where they interact with the common partner SMAD4. This SMAD complex translocates into the nucleus where it mediates activin-induced transcription. Inhibitory SMAD7, which is recruited to ACVR1B through FKBP1A, can prevent the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. Activin signal transduction is also antagonized by the binding to the receptor of inhibin-B via the IGSF1 inhibin coreceptor. ACVR1B also phosphorylates TDP2

Subcellular Localization：Cell membrane; Single-pass type I membrane protein

Expression：
Tissue_specificity:Expressed in many tissues, most strongly in kidney, pancreas, brain, lung, and liver

Isoforms & Post-Translational Modification：P36896 has 5 isomers: P36896-1: 56807 Da (predicted); P36896-2: 53411 Da (predicted); P36896-3: 54270 Da (predicted); P36896-4: 61439 Da (predicted); P36896-5: 51725 Da (predicted).
Autophosphorylated. Phosphorylated by activin receptor type-2 (ACVR2A or ACVR2B) in response to activin-binding at serine and threonine residues in the GS domain. Phosphorylation of ACVR1B by activin receptor type-2 regulates association with SMAD7;Ubiquitinated. Level of ubiquitination is regulated by the SMAD7-SMURF1 complex;Ubiquitinated

Subunit：Forms an activin receptor complex with activin receptor type-2 (ACVR2A or ACVR2B) (PubMed:8196624, PubMed:8622651, PubMed:9032295). Part of a complex consisting of MAGI2/ARIP1, ACVR2A, ACVR1B and SMAD3 (By similarity). Interacts with SMAD2 and SMAD3 (PubMed:9892009). Interacts with SMAD7 (PubMed:12023024, PubMed:16720724, PubMed:9892009). Interacts with FKBP1A (PubMed:16720724). Interacts with IGSF1 (PubMed:11266516). Interacts with CRIPTO (PubMed:11909953). Interacts with TDP2 (By similarity). Interacts with TSC22D1/TSC-22 (PubMed:21791611)

Research Field

Signal Transduction

Synonyms

ACVR1B; ACVRLK4; ALK4; Activin receptor type-1B; Activin receptor type IB; ACTR-IB; Activin receptor-like kinase 4; ALK-4; Serine/threonine-protein kinase receptor R2; SKR2

Dokumentation

Select Batch:

Data Sheet (234 KB) SDS (251 KB)

COA (205 KB)

User Guide for Antibodies (1077 KB)